Loading clinical trials...
Loading clinical trials...
The aim of this trial was to compare the safety and efficacy of courses of tobramycin and ceftazidime, administered intravenously as either thrice daily short infusions or 24 h continuous infusion, in...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Collaborators
NCT04469439 · Chronic Rhinosinusitis (Diagnosis), Cystic Fibrosis
NCT04530383 · Cystic Fibrosis-related Diabetes, Cystic Fibrosis
NCT06154447 · Cystic Fibrosis
NCT05422222 · Cystic Fibrosis
NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more
CHU Grenoble
Grenoble
Centre hospitalier Dr Schaffner
Lens
Hopital Albert Calmette
Lille
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions